cyclosporine has been researched along with Latent Tuberculosis in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bigi, L; Conti, A; Lasagni, C; Pellacani, G | 1 |
| Ball, D; Barton, E; Chancellor, A; Clifford, V; Curtis, N; Elkington, P; Fidler, K; Gao, Y; Klein, N; Mansour, S; Marshall, BG; Tebruegge, M | 1 |
| Boulinguez, S | 1 |
| Bachelez, H; Paul, C | 1 |
1 review(s) available for cyclosporine and Latent Tuberculosis
| Article | Year |
|---|---|
[Prescription and surveillance of treatment by a systemic agent or biotherapy in psoriasis].
Topics: Biological Products; Contraindications; Cyclosporine; Drug Administration Routes; Drug Monitoring; Female; Folic Acid; Humans; Immunosuppressive Agents; Kidney Diseases; Latent Tuberculosis; Liver Cirrhosis; Medical History Taking; Methotrexate; Pregnancy; Pregnancy Complications; Psoriasis; Pulmonary Fibrosis; Recurrence; Tumor Necrosis Factor-alpha; Vaccination | 2010 |
3 other study(ies) available for cyclosporine and Latent Tuberculosis
| Article | Year |
|---|---|
Successful therapy of plaque-type psoriasis with secukinumab in patients with multiple comorbidities treated with previous biologic therapies.
Topics: Adalimumab; Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Biological Therapy; Comorbidity; Cyclosporine; Etanercept; Female; Hepatitis B; Hepatitis C; Humans; Infliximab; Interleukin-17; Latent Tuberculosis; Male; Methotrexate; Middle Aged; Non-alcoholic Fatty Liver Disease; Psoriasis; Ustekinumab | 2018 |
Calcineurin Inhibitors and Variation in the Performance of Interferon-γ Release Assays Used to Detect Tuberculosis Infection.
Topics: Adult; Calcineurin Inhibitors; Chemokine CXCL10; Cyclosporine; False Negative Reactions; Graft Rejection; Humans; Interferon-gamma; Interferon-gamma Release Tests; Interleukin-2; Latent Tuberculosis; Organ Transplantation; Stem Cell Transplantation; Tacrolimus; Tumor Necrosis Factor-alpha | 2019 |
[Choice of therapy based on clinical setting].
Topics: Age Factors; Comorbidity; Contraindications; Cyclosporine; Decision Making; Dermatologic Agents; Female; Hepatic Insufficiency; Humans; Kidney Diseases; Latent Tuberculosis; Mental Disorders; Methotrexate; Pregnancy; Psoriasis; Risk Factors; Skin Neoplasms | 2011 |